Initial Combination Therapy in a Newly Diagnosed Patient
Posted July 25, 2013 by Doron Schneider, MD, FACPDoron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient.
Doron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient.
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of bariatric surgery as an initial treatment option.
Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options.
Listen to the podcast or read the transcript
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD
There is almost no other disease as pervasive as type 2 diabetes, a disease that has touched almost every family in America. Although there was a time when we had limited management tools, we now have ten classes of medications plus many kinds of insulin available as options. The result is a choice of many treatment combinations, which, however welcome, can also be overwhelming for the practicing physician. With so many choices it becomes very hard to decide what comes after metformin.
The patient centered medical home (PCMH) model has been considered a hallmark for high quality health care. Although the concept of coordinated care is fundamental to the principle of the PCMH, and although primary care teams are increasingly integrating patient- and family-centered approaches into their practice workflow for diabetes support,1 primary care physicians still need to develop a better understanding of how to coordinate population-based management of diabetes while maintaining a patient–centered approa